Evaluation of Safety and Tolerability of Libella Gene Therapy for Critical Limb Ischemia: AAV- hTERT

Clinical trial NCT04110964 · UNKNOWN

Trial details

NCT number: NCT04110964
Sponsor: Libella Gene Therapeutics
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2019-09-26
Primary completion: 2020-12-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.